Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GLAUKOS Corp Director's Dealing 2023

Sep 18, 2023

31074_dirs_2023-09-18_cfb36636-8c16-4524-8243-012dcba35131.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLAUKOS Corp (GKOS)
CIK: 0001192448
Period of Report: 2023-09-14

Reporting Person: Burns Thomas William (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-09-14 Common Stock A 4169 Acquired 54785 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-09-14 Stock Option (Right to Buy) $55.18 A 8416 Acquired 2032-03-24 Common Stock (8416) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 893932 Indirect
Common Stock 238107 Indirect
Common Stock 120000 Indirect
Common Stock 100000 Indirect
Common Stock 100000 Indirect

Footnotes

F1: Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined on September 14, 2023 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 50% of the number of shares of common stock reported herein will vest and be delivered in October 2023, and the remaining 50% will vest and be delivered in July 2024.

F2: Includes 47,177 restricted stock units that have not yet vested or been delivered to the Reporting Person.

F3: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating &
Governance Committee determined on September 14, 2023 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.

F4: 50% of the portion of the option reported herein will vest and become exercisable in October 2023, and the remaining 50% will vest and become exercisable in
July 2024.